Business Context and Reporting Period
Company: Northern Technologies International Corporation (NTIC)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended August 31, 2024
Business Overview: NTIC develops and markets proprietary corrosion prevention products (ZERUST®) and bio-based/compostable polymer resins (Natur-Tec®). Operations span over 65 countries via subsidiaries, joint ventures, and distributors. The company operates two reportable segments: ZERUST® (74.2% of sales) and Natur-Tec® (25.8% of sales).
Key Financial Metrics
| Metric | Fiscal 2024 | Fiscal 2023 |
|---|---|---|
| Net Sales | $85,059,517 | $79,902,952 |
| Gross Profit | $33,786,362 | $27,803,831 |
| Gross Margin | 39.7% | 34.8% |
| Operating Income | $7,868,483 | $6,020,646 |
| Net Income Attributable to NTIC | $5,409,082 | $2,912,276 |
| Diluted EPS | $0.55 | $0.30 |
| Operating Cash Flow | $5,883,193 | $5,541,219 |
| Working Capital | $23,682,276 | $22,950,184 |
| Total Debt (Line of Credit + Term Loans) | $7,112,443 | $6,357,176 |
| Cash and Cash Equivalents | $4,952,184 | $5,406,173 |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated net sales increased 6.5% to $85.1 million. This was driven primarily by a 20.9% increase in Natur-Tec® sales ($21.97 million) and a 2.2% increase in ZERUST® sales ($63.09 million).
- Segment Performance: ZERUST® oil & gas sales grew 18.3% to $9.23 million, offsetting a slight 0.1% decline in traditional ZERUST® industrial sales.
- Joint Venture Income: Equity in income from joint ventures decreased 34.6% to $4.22 million. This decline was largely due to the absence of a $1.99 million one-time gain from the liquidation of a former Chinese joint venture recorded in fiscal 2023, as well as softer demand in the German market.
- Profitability: Gross margin improved to 39.7% from 34.8%, attributed to lower raw material costs and the insourcing of finished goods production. Net income attributable to NTIC nearly doubled, rising from $2.91 million to $5.41 million.
- Expenses: Total operating expenses increased 5.9% to $35.4 million, primarily due to higher personnel expenses, benefits, and travel costs.
Guidance, Outlook, and Risks
- Outlook: Management anticipates continued volatility in quarterly earnings due to the cyclical nature of joint venture income and oil & gas sales. The company expects to invest in R&D ($4.8M–$5.0M in fiscal 2025) and capital expenditures ($1.6M–$2.1M in fiscal 2025) for facility improvements and ERP implementation.
- Strategic Focus: Continued expansion in the oil and gas sector and growth of the Natur-Tec® bioplastics business, supported by global regulatory trends favoring sustainable packaging.
- Key Risks:
- Supply Chain: Disruptions in international shipping (Red Sea, Panama Canal, Baltimore Bridge) have increased costs and transit times.
- Geopolitical: Ongoing conflicts (Russia-Ukraine, Israel-Hamas) and US-China tensions pose risks to operations and trade.
- Joint Venture Dependence: Liquidity relies on fees and dividends from joint ventures, which are not controlled by NTIC. The German joint venture (EXCOR) is individually significant.
- Market Dynamics: The shift toward electric vehicles may reduce demand for corrosion prevention in the automotive sector. Competition in the bioplastics market is intensifying.
- Internal Controls: A material weakness regarding the accounting for Employee Retention Credits (ERC) identified in the prior year has been remediated as of August 31, 2024.
Investor Verification Checklist
- Joint Venture Concentration: Verify the financial health and dividend payout policies of the German joint venture (EXCOR), which contributed $2.30 million to equity income in 2024.
- Oil & Gas Volatility: Assess the sustainability of the 18.3% growth in oil & gas sales given the sector's sensitivity to crude oil prices and geopolitical stability.
- Debt Covenants: Confirm continued compliance with the Fixed Charge Coverage Ratio (minimum 1.25:1.00) under the JPMorgan Chase credit facility.
- Supply Chain Costs: Monitor the impact of ongoing global shipping disruptions on gross margins and delivery timelines.
- Bioplastics Margins: Review the margin profile of the Natur-Tec® segment, which historically carries lower margins than ZERUST® products.